Prediction: Lilly Will Trade at $1,200 by Year-End
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Find which retirement index fund has the best fee and how this impacts your overall returns. Learn to spot the true cost leaders.
28,127 articlesInvestors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Ethereum slid again as it tests a crucial resistance area, with any short-term recovery fading beneath the larger dow...
Oil markets stabilize as July opens, setting up a three-stock energy play. Exxon, Chevron, and ConocoPhillips offer d...
Meta quietly positions itself as the strongest mega-cap alternative this summer, leveraging ad momentum and a new AI ...
PulteGroup accelerates its shift toward build-to-order homes to support margins as the 2026 housing market stays vola...
CrowdStrike accelerates an acquisition push as Palo Alto Networks doubles down on platform strategy. Both leaders rep...
C3.AI has faced a rough run, leaving investors wondering if a comeback is possible. This article breaks down the fact...
Ripple climbs about 5% to roughly $1.49, but analysts remain wary of a looming sell wall that could cap further gains.
AMD posted a blowout Q1 FY2026 with record revenue and booming data-center sales. The company guides stronger-than-ex...
Circle announces a $222 million Arc token presale at a $3 billion FDV, drawing major investors as quarterly revenue g...
A drone strike sparks fire near the UAE's Barakah nuclear plant, prompting swift emergency action. Officials say safe...
Elon Musk’s clash with OpenAI doubles as a bid to launch xAI, with Tesla financing and strategic partnerships setting...